Favorable cross-resistance profile of two 432 novel hepatitis C virus inhibitors, SCH-503034 and HCV-766, and enhanced anti-replicon activity mediated by the combined use of both compounds

被引：3

作者：

Howe, A. Y.

Ralston, R.

Chase, R.

Tong, X.

Skelton, A.

Flint, M.

Mullen, S.

Broom, C.

Emini, E. A.

机构：

[1] Wyeth Res, Collegeville, PA USA

[2] Schering Plough Corp, Kenilworth, NJ USA

[3] ViroPharma Inc, Exton, PA USA

来源：

关键词：

D O I：

10.1016/S0168-8278(07)62030-3

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

432

引用

页码：S165 / S165

页数：1